From
Live Event Content
2025 Pediatric Surgery Update Course - Updates in Appendicitis Management
Educational content from recorded physician discussions — not medical advice. Talk to your (or your child's) care team about your situation.
Video
2025 Pediatric Surgery Update Course - Top AI Tools of 2025
Dr. Todd Ponsky · 17 min · Published Aug 2025
Video
Quick Literature Updates Ep 24
4 min · Published Nov 2025
Video
2025 Pediatric Surgery Update Course - Updates in Pediatric Surgery feat. non-JPS Journals
Dr. Todd Ponsky · 22 min · Published Aug 2025
Video
Update Course Rewind: 2021 Top Ten Key Takeaways
Dr. Todd Ponsky · 16 min · Published Oct 2021
Video
Clinical & Research Update: Renal Tumors with Drs. Ethan Smith, Lindsay Haacker, Michael Daugherty, and Meera Kotagal
71 min · Published Sep 2026
Video
Clinical & Research Update: Neuroblastoma with Drs. Katherine Somers, Cara Morin, Juan Gurria, and Meera Kotagal
67 min · Published Sep 2026
Video
Clinical & Research Update: Sarcoma w/ Drs. Roshni Dasgupta, Joseph Pressey, Arthur Meyer, Luke Pater
66 min · Published Sep 2026
Video
2026 Laparoscopic Pediatric Hernia Repair
123 min · Published Jun 2026
Video
Beyond the Spectrum: Diagnosis, Myths & Management - Caitlin Couch & Leslie Lopez - APP Conference 2026
50 min · Published May 2026
Video
Dysautonomia: Navigating the Journey - Martha Willis - APP Conference 2026
55 min · Published May 2026
What the experts said
In Mexico private practice, no pediatric surgeons want to offer non-operative management due to trust issues - when it fails, parents seek another practitioner rather than accepting the recurrence risk.
The international randomized trial found a 26% total difference between groups, with 7% failure in the operative group (negative appendectomies) versus 34% failure in the antibiotic arm.
Parents who have been up 36 hours with a sick child don't want to hear about any recurrence rate, even when told it could be as low as 30% - they immediately opt for appendectomy.
Approximately 300 appendectomy studies reviewed over 20 years consistently show around 30% failure rate with non-operative management.
Every study has shown non-operative management is safe, which is the key finding when comparing treatment differences.
For patients requiring four-hour transfer from Eastern Washington, antibiotic treatment allows them to stay home with telehealth follow-up and later interval appendectomy, saving transfer costs and family hardship.
The adult CODA trial with 1,400 randomized patients had the exact same one-third failure rate as pediatric studies.
Early case series reported 90% success rates with non-operative management, likely because approximately 20% of those highly selected patients didn't actually have appendicitis.
In the European pilot trial by Thomas Wester and Yann Spenson, 24 patients received antibiotics, 2 failed early, and 6 of the remainder required appendectomy, though only 1 had histologically proven appendicitis.
At five-year follow-up of the European pilot trial, only 2 additional patients required appendectomy, with failures occurring relatively early.
The Midwest Pediatric Surgery Consortium non-randomized patient preference trial enrolled 1,068 patients with about one-third selecting antibiotics and had a 33% failure rate requiring operation.
Patients who respond well to antibiotics have essentially zero disability days with no somatic injury incurred.
In the outpatient management study published in JPS, 121 patients were screened with strict criteria and had a 12% appendectomy rate at one year.
Two-thirds of patients in the outpatient study went home from the ED after a single IV antibiotic dose, with one-third staying overnight, and no differences in outcomes between groups.
The Midwest pediatric study found 10 versus 6 disability days comparing surgery to antibiotics, while another study found 1 versus 4 days difference.
Multiple studies show non-operative approach is more cost-effective with higher quality-adjusted life years, even when including interval appendectomy costs.
Appendicolith has been demonstrated to reduce the effectiveness of non-operative management and increase recurrence.
Around age 14, patients have doubled the chance of failing non-operative management.
